We are live on ! Find out more
ATHE

Alterity Therapeutics
ATHE

9 hedge funds and large institutions have $227K invested in Alterity Therapeutics in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

58% more capital invested

Capital invested by funds: $144K → $227K (+$83.1K)

13% more funds holding

Funds holding: 8 → 9 (+1)

0% more ownership

Funds ownership: 0% → 0% (+0%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
9
Holders Change
+1
Holders Change %
+12.5%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$36.9K
2
VF
Virtu Financial
New York
+$26.7K
3
Morgan Stanley
Morgan Stanley
New York
+$8.89K

Top Sellers

Rank Fund Capital Flow
1
CAS
Coppell Advisory Solutions
Texas
-$356
2
UBS Group
UBS Group
Switzerland
-$315

ATHE Hedge Fund Activity: Q4 2023 in Review

9 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Alterity Therapeutics (ATHE) for Q4 2023, worth a combined $227K — up 58% from $144K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new ATHE positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Bank of Montreal, opening a new position worth an estimated $36.9K. The largest seller was Coppell Advisory Solutions, cutting an estimated $356.

  • 9 institutional investors held Alterity Therapeutics (ATHE) as of Q4 2023, up from 8 in Q3 2023.
  • Funds reported $227K of Alterity Therapeutics stock for Q4 2023, up 58% quarter-over-quarter.
  • 2 funds opened new Alterity Therapeutics positions in Q4 2023 and 1 closed out, a net change of +1 holder.
  • The largest Alterity Therapeutics buyer in Q4 2023 was Bank of Montreal, an estimated $36.9K added.
  • The largest Alterity Therapeutics seller in Q4 2023 was Coppell Advisory Solutions, an estimated $356 sold.

Based on aggregated 13F filings for Q4 2023.